α-Pyrrolidinopropiophenone (α-PPP), is a stimulant drug. It is similar in structure to the appetite suppressant diethylpropion and has analogous effects in animals. Little is known about this …

2021年6月1日 · All investigated α-pyrrolidinopropiophenone (α-PPP) derivatives are potent inhibitors of the dopamine transporter. As selective partial releasing agents at the …

KEVEYIS is a daily pill proven to reduce the number, severity and length of PPP episodes in 2 clinical studies. 1,2 It’s the first drug approved by the FDA for treatment of PPP. 1 When …

4'-Methoxy-α-pyrrolidinopropiophenone (MOPPP) is a stimulant designer drug of the pyrrolidinophenone class. It has the potential to produce euphoria, [citation needed] an effect …

2023年5月25日 · α-PPP is a synthetic stimulant drug and a pyrrolidinophenone derivative belonging to the substituted cathinone class (which itself is a member of the larger substituted …

KEVEYIS ® is a daily pill proven to treat Primary Periodic Paralysis (PPP). 1. When you live with PPP, there’s a lot you can’t control. But KEVEYIS can help. It’s the first FDA-approved …

2003年11月5日 · R,S-α-pyrrolidinopropiophenone (PPP) is a new designer drug with assumed amphetamine-like effects which has appeared on the illicit drug market. The aim of this study …

2003年11月5日 · R,S-alpha-pyrrolidinopropiophenone (PPP) is a new designer drug with assumed amphetamine-like effects which has appeared on the illicit drug market. The aim of …

We discuss this pharmacology in the context of the relative unpopularity of α‐PPP in the illicit drug scene. α‐PPP has been available on the illicit drug market for about two decades, 30 and yet …

Since the late 1990s, many derivatives of the α-pyrrolidinophenone (PPP) drug class appeared on the drugs of abuse market. The latest compound was described in 2009 to be a classic PPP …